SCANCELL HOLDINGS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.875 GBX | 0.00% |
|
+5.05% | -5.95% |
| Mar. 26 | Scancell doses first patient in melanoma-focused trials | AN |
| Mar. 22 | Seneca Growth Capital announces tepid 2023 results | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 101M | - | - | - | - | - | |
| 44.96B | - | |||||
| 42.65B | ||||||
| 41.85B | ||||||
| 29.04B | ||||||
| 26.08B |
